Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.670
-0.160 (-4.18%)
Jan 23, 2026, 3:00 PM EST - Market open

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $41.63M in the quarter ending September 30, 2025, a decrease of -39.69%. This brings the company's revenue in the last twelve months to $192.44M, down -30.47% year-over-year. In the year 2024, Maravai LifeSciences Holdings had annual revenue of $259.19M, down -10.30%.

Revenue (ttm)
$192.44M
Revenue Growth
-30.47%
P/S Ratio
2.86
Revenue / Employee
$337,605
Employees
570
Market Cap
938.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Iovance Biotherapeutics250.43M
Xencor150.13M
ARS Pharmaceuticals142.77M
Theravance Biopharma80.33M
Vir Biotechnology16.86M
Nanobiotix11.93M
Revenue Rankings